Telehealth Network Faces Renewed Customer Complaints Over Compounded GLP-1 Sales
A telehealth network specializing in compounded GLP-1s is reportedly facing new customer complaints. These allegations suggest the network has been engaging in deceptive practices. The network previously disbursed $5 million to clients as part of a settlement reached with the United States government.
A telehealth network, which provides compounded GLP-1 medications, is reportedly the subject of renewed customer complaints.
Customers have accused the network of what they describe as deceptive practices. These new allegations surface despite the network having previously been involved in a settlement with the US government. As part of that prior agreement, the network paid $5 million to its clients.
According to Wired, customers continue to report issues regarding the network's services.
